Loading stock data...
Cencora, Inc. (COR) Stock Price, Chart & Analysis
Cencora, Inc.COR
Market Closed$285.13
+$6.73+2.42%
COR Market Indicators
Neutral
Market Sentiment
Historical Price Chart
View the historical price chart for COR to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
Cencora, Inc. (COR)
Loading chart data...
Is Cencora, Inc. (COR) Stock a Buy in 2025?
YES
STRONG BUY
Score: 97/100
Yes, COR stock appears to be a good buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether COR stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
Growth Drivers
- Strong revenue growth of 12.1%
- Healthcare sector momentum
- Large-cap market leadership
Valuation Considerations
- Analyst price targets suggest 16.0% upside potential
- Mid-large cap with growth potential
Risk Factors
- High debt-to-equity ratio of 459.18
- Low current ratio indicates potential liquidity concerns
- Healthcare sector cyclicality
Analyst Consensus
Buy Ratings:8
Hold Ratings:1
Sell Ratings:1
Avg. Price Target:$330.79
Upside Potential:16.0%
Investment Summary
COR presents a mixed investment profile for 2025. The company shows strong growth drivers including strong revenue growth of 12.1%, though analyst price targets suggest 16.0% upside potential.
Analyst sentiment is generally positive with 8 buy ratings vs 1 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly high debt-to-equity ratio of 459.18, and consider their own risk tolerance and investment timeline.
Final Recommendation
STRONG BUY
Recommendation Score
Overall Score:97/100
Strong Buy
2030 Price Prediction
Predicted Price:$383.19
Potential Return:+34.4%
Key Factors
- Strong revenue growth
- Very strong analyst buy consensus
- Good upside potential
- Moderate long-term growth potential to 2030
- Good analyst consensus
- Debt-to-Market-Cap Ratio: 18.4% (Low)
Investment Decision
Based on our comprehensive analysis of COR's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a STRONG BUY. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
cor Stock Price Prediction 2030
Predicted 2030 Price
$383.19
+34.4%from current price
Based on revenue growth analysis and market trends, cor stock is projected to reach $383.19 by 2030, representing a 34.4% increase from the current price of $285.13.
Current Price
$285.13
Revenue Growth
8.7%
Analyst Target
$330.79
View Full Prediction Analysis
Get detailed analyst targets, key factors, and comprehensive forecast analysis
How to Invest in cor Stock?
Quick Investment Insights for cor
High P/E: 29.24Low Volatility (Beta: 0.58)
1. Research Fundamentals
Analyze financial statements and market position
2. Technical Analysis
Review price charts and technical indicators
3. Risk Assessment
Evaluate market and company-specific risks
Company Profile
Cencora, Inc.
Healthcare
Medical Distribution
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter he...
Employees
51,000
Market Cap
$55.28B